Design and optimizing a novel ocular plaque brachytherapy with dual-core of 103Pd and 106Ru

Analysis of dose to the macula, optic disc, and lens in relation to vision toxicities – A retrospective study using COMS eye plaques

“…When such methods are used clinically, relevant dose-outcome relationships should be analyzed. Only 125 I COMS plaques were used in this study, leaving questions remaining for other plaque manufacturers and isotopes, especially betaemitting sources or even the recently-proposed dual-core eye plaque [44]. Similar studies need to be performed to make equivalent conclusions.…”